Neurogene (NGNE) Capital Leases (2015 - 2026)

Neurogene's (NGNE) quarterly Capital Leases came in at $4000.0 in Q1 2026, down 76.47% YoY from $17000.0 in Q1 2025, and down 20.0% on a QoQ basis from $5000.0 in Q4 2025.

Neurogene (NGNE) Capital Leases (2015 - 2026) Analysis & Trends

Neurogene (NGNE) has 12 years of Capital Leases data on file, last reported at $4000.0 in Q1 2026.

  • Quarterly Capital Leases fell 76.47% year-over-year to $4000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4000.0 (down 76.47% YoY) and the FY2025 annual result came in at $5000.0, down 80.77% from the prior year.
  • Capital Leases fell to $4000.0 in Q1 2026, from $5000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $66000.0 in Q1 2022 to a low of $4000.0 in Q1 2026.
  • A 5-year average of $26294.1 and a median of $10000.0 in 2022 frame the typical range for Capital Leases.
  • Annual changes were most pronounced in 2023 — Capital Leases sank 89.39% — and 2024, when it jumped 783.33%.
  • Tracing NGNE's Capital Leases over 5 years: stood at $66000.0 in 2022, then dropped by 1.52% to $65000.0 in 2023, then slumped by 60.0% to $26000.0 in 2024, then plunged by 80.77% to $5000.0 in 2025, then slipped by 20.0% to $4000.0 in 2026.
  • The last three Capital Leases figures came in at $4000.0 (Q1 2026), $5000.0 (Q4 2025), and $7000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Neurogene 815.03 Mn 815.03 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 3,000.00
Mar 31, 2026 4,000.00
Dec 31, 2025 5,000.00
Sep 30, 2025 7,000.00
Jun 30, 2025 9,000.00
Mar 31, 2025 17,000.00
Dec 31, 2024 26,000.00
Sep 30, 2024 39,000.00
Jun 30, 2024 53,000.00
Mar 31, 2024 53,000.00
Dec 31, 2023 65,000.00
Sep 30, 2023 5,000.00
Jun 30, 2023 6,000.00
Mar 31, 2023 7,000.00
Dec 31, 2022 66,000.00
Sep 30, 2022 9,000.00
Jun 30, 2022 10,000.00
Mar 31, 2022 66,000.00
Dec 31, 2021 67,000.00
Sep 30, 2021 68,000.00